Do women with HIV infection have different indications for hysterectomy? [2]

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 3, 2005, Pages 378-379

  Paramsothy, Pangaja ^a   Crouse, Chadd ^b   Ahmed, Yusuf ^b   Duerr, Ann ^b,c   Davis, Xiaohong M ^b   Jamieson, Denise J ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CESAREAN SECTION; ENDOMETRIOSIS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYSTERECTOMY; LEIOMYOMA; LETTER; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OVARIECTOMY; PELVIC ORGAN PROLAPSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT INDICATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; HIV INFECTIONS; HUMANS; HYSTERECTOMY; MENSTRUATION DISTURBANCES; MIDDLE AGED; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 21544436842     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000164026.97425.be     Document Type: Letter

References (9)

1. Lepine L, Hillis S, Marchbanks P, et al. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ. 1997;46:1-15.
2. Keshavarz H, Hillis S, Kieke BA, et al. Hysterectomy surveillance-United States 1994-1999. MMWR CDC Surveill Summ. 2002;51:1-8.
3. Farquhar C, Steiner C. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol. 2002; 99:229-234.
4. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
5. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184: 682-690.
6. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226-236.
7. Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337:1343-1349.
8. Conti M, Agarossi A, Parazini F, et al. HPV, HIV infection and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol Oncol. 1993;49:344-348.
9. Wright TCJ, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears: New York Cervical Disease study. Obstet Gynecol. 1994;84:591-597.